Kalshi· Science and Technology

When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression?

Chance

87%

Buy Yes

90¢

pays $1 if it happens

Buy No

17¢

pays $1 if it doesn’t

Prices from Kalshi, updated 3 minutes ago. Ends Oct 1, 3:59 AM UTC.

Price over the last 2 weeks

Cost of a Yes share

How this market is decidedShow

If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Oct 1, 2027, then the market resolves to Yes.